Relating to the establishment of a grant program to fund the United States Food and Drug Administration’s drug development trials with ibogaine

Looking ahead

No hearings or votes scheduled.

History

1. 2026
   1. Apr 2Vetoed by Governor Patrick Morrisey 4/1/2026Latest
   2. Mar 31To Governor 3/31/2026To Governor
   3. Mar 14Vetoed by Governor Patrick Morrisey 4/1/2026 - House JournalMajor
   4. Mar 14Vetoed by Governor Patrick Morrisey 4/1/2026 - Senate JournalMajor
   5. Mar 14To Governor 3/31/2026 - Senate JournalMinor
   6. Mar 13House received Senate message
   7. Mar 12Completed legislative action
      • Vote recorded Passage. Result: pass.Upper
   8. Mar 12Communicated to House
   9. Mar 12Passed Senate (Roll No. 487)Passed Senate
   10. Mar 12Read 3rd timeMinor
   11. Mar 12On 3rd reading
   12. Mar 11Read 2nd timeMinor
   13. Mar 11On 2nd reading
   14. Mar 10Read 1st timeMinor
   15. Mar 10On 1st reading
   16. Mar 9Reported do passMinor
   17. Feb 18To FinanceMinor
   18. Feb 18Reported do pass, but first to FinanceMinor
   19. Jan 30To Health and Human ResourcesMinor
   20. Jan 30To Health and Human Resources then FinanceMinor
   21. Jan 30Introduced in SenateMinor
   22. Jan 29Communicated to Senate
       • Vote recorded PASSAGE. Result: pass.Lower
   23. Jan 29Passed House (Roll No. 32)Passed House
   24. Jan 29Read 3rd timeMinor
   25. Jan 29On 3rd reading, Special Calendar
   26. Jan 28Read 2nd timeMinor
   27. Jan 28On 2nd reading, Special Calendar
   28. Jan 27Read 1st timeMinor
   29. Jan 27On 1st reading, Special Calendar
   30. Jan 26On 1st reading, Special Calendar
   31. Jan 23Do pass
   32. Jan 22Markup Discussion
   33. Jan 21To House Health and Human ResourcesMinor
   34. Jan 21Introduced in HouseMinor
   35. Jan 21To Health and Human ResourcesMinor
   36. Jan 21Filed for introductionIntroduced